Balance Sheet for BioXcel Therapeutics Inc. (BTAI)

$ 45.30   -2.01 (-4.25%) Volume: 91.04k 11:27 AM EDT Jun 2, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Cash and Equivalents 32,426 42,565 887 -
Restrictable Cash - - - -
Marketable Securities - - - -
Accounts Receivable - 115 - -
Loans Receivable - - - -
Other Receivables - - - -
Receivables - 115 - -
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 1,681 491 3 2
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 34,107 43,171 890 2
Land and Improvements - - - -
Buildings and Improvement 642 172 - -
Machinery, Furniture and Equipment 573 173 5 5
Construction in Progress - - - -
Fixed Assets, Other 1,193 - - -
Fixed Assets, Total 2,408 345 5 5
Gross Fixed Assets 2,408 345 5 5
Accumulated Depreciation (174) (18) (1) -
Net Fixed Assets 2,234 327 4 5
Intangibles - - - -
Cost in Excess - - - -
Non-Current Deferred Income Taxes - - - -
Other Non-Current Assets 51 51 - -
Total Non-Current Assets 2,285 378 465 5
Total Assets 36,392 43,549 1,355 7
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Accounts Payable 5,017 1,604 951 279
Short Term Debt - - 371 -
Notes Payable - - - -
Accrued Expenses 3,120 3,056 1,015 25
Accrued Liabilities 3,120 3,056 1,015 25
Deferred Revenues - - - -
Current Deferred Income Taxes - - - -
Other Current Liabilities 331 - - 27
Total Current Liabilities 8,468 4,660 2,337 331
Long Term Debt N/A N/A - -
Deferred Income Tax - - - -
Other Non-Current Liabilities - - - -
Minority Interest - - - -
Capital Lease Obligations 1,029 - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - - - -
Total Non-Current Liabilities 1,029 - - -
Total Liabilities 9,497 4,660 2,337 331
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 26,895 38,889 (982) (324)
Common Par 18 16 10 -
Additional Paid in Capital 83,565 62,593 3,458 -
Cumulative Translation Adjustments - - - -
Retained Earnings (56,688) (23,720) (4,450) -
Treasury Stock - - - -
Other Equity Adjustments - - - -
Total Capitalization 26,895 38,889 (982) (324)
Total Equity 26,895 38,889 (982) (324)
Total Liabilities & Shareholder's Equity 36,392 43,549 1,355 7
Cash Flow (32,968) (19,270) (4,539) (2,120)
Working Capital 25,639 38,511 (1,447) (329)
Free Cash Flow (28,150) (13,849) (2,196) (1,298)
Invested Capital 26,895 38,889 (982) (324)
Shares Outstanding - Common Class Only 18,087 15,663 - -
Preferred Shares Outstanding - - - -
Total Ordinary Shares 18,087 15,663 15,191 15,191
Total Common Shares Outstanding 18,087 15,663 - -
Treasury Shares - - - -
Basic Weighted Shares Outstanding 16,289 14,572 15,191 15,646
Diluted Weighted Shares Outstanding 16,289 14,572 15,191 15,646